BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36125911)

  • 1. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
    Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cathepsin C in PR3-ANCA Vasculitis.
    Jerke U; Eulenberg-Gustavus C; Rousselle A; Nicklin P; Kreideweiss S; Grundl MA; Eickholz P; Nickles K; Schreiber A; Korkmaz B; Kettritz R
    J Am Soc Nephrol; 2022 May; 33(5):936-947. PubMed ID: 35292437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
    Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
    J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
    J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA.
    Gong Y; Shen C; Meng T; Lin W; Hu X; Tang R; Xiong Q; Ooi JD; Eggenhuizen PJ; Chen J; Zhou YO; Luo H; Xu J; Liu N; Xiao P; Xiao X; Zhong Y
    Clin Exp Med; 2024 Apr; 24(1):66. PubMed ID: 38564029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens.
    Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ
    Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies.
    Walulik A; Łysak K; Błaszkiewicz M; Górecki I; Gomułka K
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitively disrupting the neutrophil-specific receptor-autoantigen CD177:proteinase 3 membrane complex reduces anti-PR3 antibody-induced neutrophil activation.
    Marino SF; Jerke U; Rolle S; Daumke O; Kettritz R
    J Biol Chem; 2022 Mar; 298(3):101598. PubMed ID: 35063507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
    van Dam LS; Dirikgil E; Bredewold EW; Ray A; Bakker JA; van Kooten C; Rabelink TJ; Teng YKO
    Nephrol Dial Transplant; 2021 Jul; 36(8):1408-1417. PubMed ID: 32601673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.
    Ohlsson S; Wieslander J; Segelmark M
    Clin Exp Immunol; 2003 Mar; 131(3):528-35. PubMed ID: 12605707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.